Karyopharm Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KPTI and other ETFs, options, and stocks.About KPTI
Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A.
KPTI Key Statistics
Stock Snapshot
As of today, Karyopharm Therapeutics(KPTI) shares are valued at $2.08. The company's market cap stands at 47.03M, with a P/E ratio of -0.13.
On 2026-08-07, Karyopharm Therapeutics(KPTI) stock traded between a low of $1.91 and a high of $2.08. Shares are currently priced at $2.08, which is +8.6% above the low and -0.2% below the high.
The Karyopharm Therapeutics(KPTI)'s current trading volume is 1.21M, compared to an average daily volume of 4.12M.
In the last year, Karyopharm Therapeutics(KPTI) shares hit a 52-week high of $10.99 and a 52-week low of $1.80.
In the last year, Karyopharm Therapeutics(KPTI) shares hit a 52-week high of $10.99 and a 52-week low of $1.80.
Analyst ratings
71%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.